aluates Reports

$ 0.0

Automative

Global Gene Therapy For Heart Failure Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-3H13677

Global Gene Therapy For Heart Failure Market Research Report 2023

BUY CHAPTERS

Global Gene Therapy For Heart Failure Market Research Report 2025

Code: QYRE-Auto-3H13677

Report

June 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Askbio

RENOVACORINC

Uniqure

DINAQOR

PRECIGEN

Heartseed

Cardior

Novartis

Blue Rock

Gene Therapy For Heart Failure Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gene Therapy For Heart Failure Market

The global market for Gene Therapy For Heart Failure was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Gene therapy provides a novel strategy for targeting abnormalities in heart cells that adversely affect heart function.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gene Therapy For Heart Failure, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy For Heart Failure.

The Gene Therapy For Heart Failure market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy For Heart Failure market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy For Heart Failure companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapy For Heart Failure Market Report

Report Metric	Details
Report Name	Gene Therapy For Heart Failure Market
CAGR	5%
Segment by Type	Gene Modification Gene Replacement Others
Segment by Application	Hospital Laboratory Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Askbio, RENOVACORINC, Uniqure, DINAQOR, PRECIGEN, Heartseed, Cardior, NOVARTIS, Blue Rock
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy For Heart Failure company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapy For Heart Failure Market report?

Ans: The main players in the Gene Therapy For Heart Failure Market are Askbio, RENOVACORINC, Uniqure, DINAQOR, PRECIGEN, Heartseed, Cardior, NOVARTIS, Blue Rock

What are the Application segmentation covered in the Gene Therapy For Heart Failure Market report?

Ans: The Applications covered in the Gene Therapy For Heart Failure Market report are Hospital, Laboratory, Others

What are the Type segmentation covered in the Gene Therapy For Heart Failure Market report?

Ans: The Types covered in the Gene Therapy For Heart Failure Market report are Gene Modification, Gene Replacement, Others

Recommended Reports

Gene Therapy Markets

Heart Disease Therapy

Genetic Disorders & Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy For Heart Failure Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Gene Modification

1.2.3 Gene Replacement

1.2.4 Others

1.3 Market by Application

1.3.1 Global Gene Therapy For Heart Failure Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Laboratory

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy For Heart Failure Market Perspective (2020-2031)

2.2 Global Gene Therapy For Heart Failure Growth Trends by Region

2.2.1 Global Gene Therapy For Heart Failure Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Therapy For Heart Failure Historic Market Size by Region (2020-2025)

2.2.3 Gene Therapy For Heart Failure Forecasted Market Size by Region (2026-2031)

2.3 Gene Therapy For Heart Failure Market Dynamics

2.3.1 Gene Therapy For Heart Failure Industry Trends

2.3.2 Gene Therapy For Heart Failure Market Drivers

2.3.3 Gene Therapy For Heart Failure Market Challenges

2.3.4 Gene Therapy For Heart Failure Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy For Heart Failure Players by Revenue

3.1.1 Global Top Gene Therapy For Heart Failure Players by Revenue (2020-2025)

3.1.2 Global Gene Therapy For Heart Failure Revenue Market Share by Players (2020-2025)

3.2 Global Gene Therapy For Heart Failure Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Therapy For Heart Failure Revenue

3.4 Global Gene Therapy For Heart Failure Market Concentration Ratio

3.4.1 Global Gene Therapy For Heart Failure Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy For Heart Failure Revenue in 2024

3.5 Global Key Players of Gene Therapy For Heart Failure Head office and Area Served

3.6 Global Key Players of Gene Therapy For Heart Failure, Product and Application

3.7 Global Key Players of Gene Therapy For Heart Failure, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy For Heart Failure Breakdown Data by Type

4.1 Global Gene Therapy For Heart Failure Historic Market Size by Type (2020-2025)

4.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2026-2031)

5 Gene Therapy For Heart Failure Breakdown Data by Application

5.1 Global Gene Therapy For Heart Failure Historic Market Size by Application (2020-2025)

5.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Therapy For Heart Failure Market Size (2020-2031)

6.2 North America Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Therapy For Heart Failure Market Size by Country (2020-2025)

6.4 North America Gene Therapy For Heart Failure Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapy For Heart Failure Market Size (2020-2031)

7.2 Europe Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Therapy For Heart Failure Market Size by Country (2020-2025)

7.4 Europe Gene Therapy For Heart Failure Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy For Heart Failure Market Size (2020-2031)

8.2 Asia-Pacific Gene Therapy For Heart Failure Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapy For Heart Failure Market Size (2020-2031)

9.2 Latin America Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Therapy For Heart Failure Market Size by Country (2020-2025)

9.4 Latin America Gene Therapy For Heart Failure Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy For Heart Failure Market Size (2020-2031)

10.2 Middle East & Africa Gene Therapy For Heart Failure Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Askbio

11.1.1 Askbio Company Details

11.1.2 Askbio Business Overview

11.1.3 Askbio Gene Therapy For Heart Failure Introduction

11.1.4 Askbio Revenue in Gene Therapy For Heart Failure Business (2020-2025)

11.1.5 Askbio Recent Development

11.2 RENOVACORINC

11.2.1 RENOVACORINC Company Details

11.2.2 RENOVACORINC Business Overview

11.2.3 RENOVACORINC Gene Therapy For Heart Failure Introduction

11.2.4 RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2020-2025)

11.2.5 RENOVACORINC Recent Development

11.3 Uniqure

11.3.1 Uniqure Company Details

11.3.2 Uniqure Business Overview

11.3.3 Uniqure Gene Therapy For Heart Failure Introduction

11.3.4 Uniqure Revenue in Gene Therapy For Heart Failure Business (2020-2025)

11.3.5 Uniqure Recent Development

11.4 DINAQOR

11.4.1 DINAQOR Company Details

11.4.2 DINAQOR Business Overview

11.4.3 DINAQOR Gene Therapy For Heart Failure Introduction

11.4.4 DINAQOR Revenue in Gene Therapy For Heart Failure Business (2020-2025)

11.4.5 DINAQOR Recent Development

11.5 PRECIGEN

11.5.1 PRECIGEN Company Details

11.5.2 PRECIGEN Business Overview

11.5.3 PRECIGEN Gene Therapy For Heart Failure Introduction

11.5.4 PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2020-2025)

11.5.5 PRECIGEN Recent Development

11.6 Heartseed

11.6.1 Heartseed Company Details

11.6.2 Heartseed Business Overview

11.6.3 Heartseed Gene Therapy For Heart Failure Introduction

11.6.4 Heartseed Revenue in Gene Therapy For Heart Failure Business (2020-2025)

11.6.5 Heartseed Recent Development

11.7 Cardior

11.7.1 Cardior Company Details

11.7.2 Cardior Business Overview

11.7.3 Cardior Gene Therapy For Heart Failure Introduction

11.7.4 Cardior Revenue in Gene Therapy For Heart Failure Business (2020-2025)

11.7.5 Cardior Recent Development

11.8 NOVARTIS

11.8.1 NOVARTIS Company Details

11.8.2 NOVARTIS Business Overview

11.8.3 NOVARTIS Gene Therapy For Heart Failure Introduction

11.8.4 NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2020-2025)

11.8.5 NOVARTIS Recent Development

11.9 Blue Rock

11.9.1 Blue Rock Company Details

11.9.2 Blue Rock Business Overview

11.9.3 Blue Rock Gene Therapy For Heart Failure Introduction

11.9.4 Blue Rock Revenue in Gene Therapy For Heart Failure Business (2020-2025)

11.9.5 Blue Rock Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Askbio

RENOVACORINC

Uniqure

DINAQOR

PRECIGEN

Heartseed

Cardior

Novartis

Blue Rock

List of Tables

Table 1. Global Gene Therapy For Heart Failure Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Gene Modification

Table 3. Key Players of Gene Replacement

Table 4. Key Players of Others

Table 5. Global Gene Therapy For Heart Failure Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gene Therapy For Heart Failure Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gene Therapy For Heart Failure Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Gene Therapy For Heart Failure Market Share by Region (2020-2025)

Table 9. Global Gene Therapy For Heart Failure Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Gene Therapy For Heart Failure Market Share by Region (2026-2031)

Table 11. Gene Therapy For Heart Failure Market Trends

Table 12. Gene Therapy For Heart Failure Market Drivers

Table 13. Gene Therapy For Heart Failure Market Challenges

Table 14. Gene Therapy For Heart Failure Market Restraints

Table 15. Global Gene Therapy For Heart Failure Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Gene Therapy For Heart Failure Market Share by Players (2020-2025)

Table 17. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2024)

Table 18. Ranking of Global Top Gene Therapy For Heart Failure Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Gene Therapy For Heart Failure Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Gene Therapy For Heart Failure, Headquarters and Area Served

Table 21. Global Key Players of Gene Therapy For Heart Failure, Product and Application

Table 22. Global Key Players of Gene Therapy For Heart Failure, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gene Therapy For Heart Failure Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2020-2025)

Table 26. Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2026-2031)

Table 28. Global Gene Therapy For Heart Failure Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2020-2025)

Table 30. Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2026-2031)

Table 32. North America Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Gene Therapy For Heart Failure Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Gene Therapy For Heart Failure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2026-2031) & (US$ Million)

Table 47. Askbio Company Details

Table 48. Askbio Business Overview

Table 49. Askbio Gene Therapy For Heart Failure Product

Table 50. Askbio Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)

Table 51. Askbio Recent Development

Table 52. RENOVACORINC Company Details

Table 53. RENOVACORINC Business Overview

Table 54. RENOVACORINC Gene Therapy For Heart Failure Product

Table 55. RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)

Table 56. RENOVACORINC Recent Development

Table 57. Uniqure Company Details

Table 58. Uniqure Business Overview

Table 59. Uniqure Gene Therapy For Heart Failure Product

Table 60. Uniqure Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)

Table 61. Uniqure Recent Development

Table 62. DINAQOR Company Details

Table 63. DINAQOR Business Overview

Table 64. DINAQOR Gene Therapy For Heart Failure Product

Table 65. DINAQOR Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)

Table 66. DINAQOR Recent Development

Table 67. PRECIGEN Company Details

Table 68. PRECIGEN Business Overview

Table 69. PRECIGEN Gene Therapy For Heart Failure Product

Table 70. PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)

Table 71. PRECIGEN Recent Development

Table 72. Heartseed Company Details

Table 73. Heartseed Business Overview

Table 74. Heartseed Gene Therapy For Heart Failure Product

Table 75. Heartseed Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)

Table 76. Heartseed Recent Development

Table 77. Cardior Company Details

Table 78. Cardior Business Overview

Table 79. Cardior Gene Therapy For Heart Failure Product

Table 80. Cardior Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)

Table 81. Cardior Recent Development

Table 82. NOVARTIS Company Details

Table 83. NOVARTIS Business Overview

Table 84. NOVARTIS Gene Therapy For Heart Failure Product

Table 85. NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)

Table 86. NOVARTIS Recent Development

Table 87. Blue Rock Company Details

Table 88. Blue Rock Business Overview

Table 89. Blue Rock Gene Therapy For Heart Failure Product

Table 90. Blue Rock Revenue in Gene Therapy For Heart Failure Business (2020-2025) & (US$ Million)

Table 91. Blue Rock Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Gene Therapy For Heart Failure Picture

Figure 2. Global Gene Therapy For Heart Failure Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Therapy For Heart Failure Market Share by Type: 2024 VS 2031

Figure 4. Gene Modification Features

Figure 5. Gene Replacement Features

Figure 6. Others Features

Figure 7. Global Gene Therapy For Heart Failure Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Gene Therapy For Heart Failure Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Laboratory Case Studies

Figure 11. Others Case Studies

Figure 12. Gene Therapy For Heart Failure Report Years Considered

Figure 13. Global Gene Therapy For Heart Failure Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Gene Therapy For Heart Failure Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Gene Therapy For Heart Failure Market Share by Region: 2024 VS 2031

Figure 16. Global Gene Therapy For Heart Failure Market Share by Players in 2024

Figure 17. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy For Heart Failure Revenue in 2024

Figure 19. North America Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Gene Therapy For Heart Failure Market Share by Country (2020-2031)

Figure 21. United States Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Gene Therapy For Heart Failure Market Share by Country (2020-2031)

Figure 25. Germany Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Gene Therapy For Heart Failure Market Share by Region (2020-2031)

Figure 33. China Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Gene Therapy For Heart Failure Market Share by Country (2020-2031)

Figure 41. Mexico Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Gene Therapy For Heart Failure Market Share by Country (2020-2031)

Figure 45. Turkey Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Gene Therapy For Heart Failure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Askbio Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)

Figure 49. RENOVACORINC Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)

Figure 50. Uniqure Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)

Figure 51. DINAQOR Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)

Figure 52. PRECIGEN Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)

Figure 53. Heartseed Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)

Figure 54. Cardior Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)

Figure 55. NOVARTIS Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)

Figure 56. Blue Rock Revenue Growth Rate in Gene Therapy For Heart Failure Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global In Vitro Gene Therapy Market Research Report 2025

Global Cell and Gene Therapy Solutions Market Research Report 2025

Global Hemophilia Gene Therapy Market Research Report 2025

Global Gene Therapy in Oncology Market Research Report 2024

Global Non viral Vectors Gene Therapy Market Research Report 2025

Global Gene Therapy for CNS Disorders Market Research Report 2024

Global Ocular Gene Therapy Market Research Report 2024

Gene Therapy Cell Culture Medias Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Optogenetic Gene Therapy Market Research Report 2024

Gene Therapy in Cardiovascular Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adeno Associated Virus AAV Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy Drug Delivery Tube Market Research Report 2024

Gene Therapy Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy On Cardiovascular Disease Market Research Report 2025

Cell and Gene Therapy Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Osteoarthritis Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy in CNS Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug and Gene Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions